Zobrazeno 1 - 10
of 91
pro vyhledávání: '"M.N. Lopes"'
Autor:
S.R. Maranhão, R.C.F.F. Pompeu, H.A. Souza, M.J.D. Cândido, R.G. Fontinele, M.N. Lopes, A.C.R. Cavalcante, M.C.P. Rogério, F.L. Guedes
Publikováno v:
Arquivo Brasileiro de Medicina Veterinária e Zootecnia, Vol 76, Iss 3 (2024)
ABSTRACT This work aimed to evaluate the physiological parameters, the biomass flow, and the productive characteristics of the grasses BRS Piatã and BRS Paiaguás at different levels of water supply in the semi-arid region. The experiment was carrie
Externí odkaz:
https://doaj.org/article/b66afb8b268645ef884bd08abba0611a
Autor:
Josephine M.N. Lopes Cardozo, Sherylene E. Veira, Laila Ait Hassou, Aimé Lambert Uwimana, Ivana Božović-Spasojević, Jan Bogaerts, Fatima Cardoso, Marjanka K. Schmidt, Emiel J.T. Rutgers, Coralie Poncet, Caroline A. Drukker
Publikováno v:
Breast, Vol 71, Iss , Pp 143-149 (2023)
Purpose: Tailored recommendation for adjuvant chemotherapy in breast cancer patients is of great importance. This survey assessed agreement among oncologists on risk assessment and chemotherapy recommendation, the impact of adding the 70-gene signatu
Externí odkaz:
https://doaj.org/article/68f1f4a4ff414d15974d53b8922bcb3a
Autor:
M.N. Lopes, M.J.D. Cândido, R.C.F.F. Pompeu, R.G. Silva, M.S.S. Carneiro, L.B. Morais Neto, M.J.A. Peixoto, T.C.F. Carvalho
Publikováno v:
Arquivo Brasileiro de Medicina Veterinária e Zootecnia
ABSTRACT To evaluate the biomass components of massai grass subjected to nitrogen (N) fertilization levels (control - 0; 400; 800 and 1200 kg ha-1 year-1 of N) and under rotational stocking with sheep, this study was undertaken using a completely ran
Externí odkaz:
https://doaj.org/article/1be105470a304780bbca300091e9d1c8
Publikováno v:
Acta Horticulturae. :155-162
Autor:
Khalil Zaman, Giuseppe Viale, Martine Picccart, Suzette Delaloge, Isabel T. Rubio, C. Poncet, Laura J. van't Veer, Gabriele Zoppoli, Sherko Kümmel, Etienne Brain, Peter Vuylsteke, Emiel J. Th. Rutgers, Jean-Yves Pierga, Florentine Hilbers, Aleksandra Peric, Josephine M.N. Lopes Cardozo, Bart Meulemans, Erika Matos, Susan J. Knox, A. Thompson, Fatima Cardoso
Publikováno v:
Cancer Research. 81:GS4-11
Background With 8.7 years follow-up, the prospective phase III randomized MINDACT trial (EORTC 10041/BIG3-04) continues to meet its primary objective, i.e. 95.1% (95%CI 93.1-96.6), 5-year distant metastasis-free survival (DMFS) in clinical high (C-Hi
Autor:
Josephine M.N. Lopes Cardozo, Caroline A. Drukker, Emiel J.T. Rutgers, Marjanka K. Schmidt, Annuska M. Glas, Anke Witteveen, Fatima Cardoso, Martine Piccart, Laura J. Esserman, Coralie Poncet, Laura J. van 't Veer
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(12)
PURPOSE Patients with 70-gene signature ultralow-risk breast cancers have shown excellent survival in historic cohorts, including randomized trials. The ultralow-risk subgroup was characterized to help avoid overtreatment. We evaluated outcomes of ul
Autor:
Josephine M.N. Lopes Cardozo, Sherylene E. Veira, Laila Ait Hassou, Aimé Lambert Uwimana, Ivana Božović-Spasojević, Jan Bogaerts, Fatima Cardoso, Marjanka K. Schmidt, Emiel J.T. Rutgers, Coralie Poncet, Caroline A. Drukker
Publikováno v:
European Journal of Cancer. 175:S64
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mauro Delorenzi, Sherko Kümmel, Peter Vuylsteke, Debora Fumagalli, Christos Sotiriou, Suzan Vrijaldenhoven, Suzette Delaloge, Konstantinos Tryfonidis, Sylvian Causeret, Etienne Brain, Laura J. van't Veer, Emiel J. Th. Rutgers, Gabriele Zoppoli, Jan Bogaerts, Bart Meulemans, Jean-Yves Pierga, Fatima Cardoso, Florentine Hilbers, Aleksandra Peric, Peter M. Ravdin, Josephine M.N. Lopes Cardozo, Tineke J. Smilde, Annuska M. Glas, Giuseppe Viale, Susan J. Knox, C. Poncet, Isabel T. Rubio, Peter A. Neijenhuis, Erika Matos, Martine Piccart, Khalil Zaman, Alastair M. Thompson
Publikováno v:
Lancet oncology
The MINDACT trial showed excellent 5-year distant metastasis-free survival of 94·7% (95% CI 92·5-96·2) in patients with breast cancer of high clinical and low genomic risk who did not receive chemotherapy. We present long-term follow-up results to
Autor:
C. Poncet, Konstantinos Tryfonidis, Jean-Yves Pierga, Laura J. van't Veer, Josephine M.N. Lopes Cardozo, Tineke J. Smilde, Annuska M. Glas, Aleksandra Peric, Erika Matos, Florentine Hilbers, Peter Vuylsteke, Gabrielle Zoppoli, Peter M. Ravdin, Susan J. Knox, Bart Meulemans, Sylvian Causeret, Suzan Vrijaldenhoven, Sherko Kümmel, Suzette Delaloge, Christos Sotiriou, Mauro Delorenzi, Fatima Cardoso, Jan Bogaerts, Martine Piccart, Emiel J. Th. Rutgers, Debora Fumagalli, Peter A. Neijenhuis, Isabel T. Rubio, G. Viale, Etienne Brain, Khalil Zaman, Alastair M. Thompson
Publikováno v:
SSRN Electronic Journal.
Background: The MINDACT trial showed excellent 5-year distant metastasis-free survival (DMFS) of 94·7% (95%CI 92·5-96·2) in clinical high (C-High)/genomic low (G-Low) risk patients who did not receive chemotherapy. Long-term follow-up is presented